HUMBOLDT CAPITAL, LLC
HUMBOLDT CAPITAL, LLC is a Pre-seed, Seed and Series A fund in the US writing $500K+ checks into Climate, Healthcare, biotechnology, synthetic-biology, chemicals, materials, food-and-beverage, molecular-biology, biomaterials, genetics, mechanical-engineering and therapeutics.
- Stages
- Pre-seed, Seed, Series A
- Sectors
- Climate, Healthcare, biotechnology, synthetic-biology, chemicals, materials, food-and-beverage, molecular-biology, biomaterials, genetics, mechanical-engineering, therapeutics
- Check size
- $500K+
- Invests in
- US-wide
- Round role
- Leads rounds
- Website
- humboldtfund.com
Thesis
Humboldt Fund is a venture capital firm founded in 2020 and based in New York, focusing on early-stage investments in biotechnology and synthetic biology. The firm targets innovative companies leveraging engineering, physical sciences, and life sciences to develop new technologies in chemicals, materials, food, and medicines. Their geographic scope is primarily North America, with a focus on the United States. Humboldt Fund actively leads investments, typically writing checks between $500,000 and $1 million. While specific AUM figures are not disclosed, Humboldt Capital, LLC, as an investment adviser, reported one private fund with a gross asset value of $52.42 million as of March 27, 2026.
Common questions
Does HUMBOLDT CAPITAL, LLC invest at the Pre-seed stage?
Yes. HUMBOLDT CAPITAL, LLC lists Pre-seed, Seed and Series A among the stages it invests in.
What check size does HUMBOLDT CAPITAL, LLC write?
HUMBOLDT CAPITAL, LLC writes $500K+ checks.
Where does HUMBOLDT CAPITAL, LLC invest?
HUMBOLDT CAPITAL, LLC invests in the US.